Balyasny Asset Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.63M Buy
+298,955
New +$11.1M 0.01% 1050
2025
Q4
Sell
-29,965
Closed -$1.03M 3591
2025
Q3
$1.03M Sell
29,965
-140,283
-82% -$4.02M ﹤0.01% 2105
2025
Q2
$4.6M Buy
+170,248
New +$4.93M 0.01% 1328
2023
Q4
Sell
-102,178
Closed -$2.28M 2938
2023
Q3
$2.28M Buy
102,178
+79,741
+355% +$2.05M ﹤0.01% 1342
2023
Q2
$571K Sell
22,437
-27,103
-55% -$657K ﹤0.01% 1808
2023
Q1
$1.1M Buy
49,540
+49,373
+29,565% +$1.19M ﹤0.01% 1705
2022
Q4
$3.96K Sell
167
-17,932
-99% -$417K ﹤0.01% 2641
2022
Q3
$301K Buy
+18,099
New +$407K ﹤0.01% 2195
2022
Q1
Sell
-192,536
Closed -$7.93M 2873
2021
Q4
$7.93M Sell
192,536
-30,976
-14% -$1.37M 0.03% 705
2021
Q3
$10.4M Buy
+223,512
New +$9.75M 0.04% 564
2020
Q4
Sell
-220,952
Closed -$7.18M 1726
2020
Q3
$7.18M Sell
220,952
-36,537
-14% -$1.16M 0.05% 496
2020
Q2
$6.67M Buy
+257,489
New +$6.42M 0.06% 439

Other funds holding VCYT

Balyasny Asset Management's VCYT Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in Veracyte (VCYT) in Q1 2026: 298,955 shares worth $9.63M. The stake represents 0.01% of the portfolio and ranks #1050 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in VCYT as recently as Q3 2025.

Balyasny Asset Management first reported a position in VCYT in Q2 2020 and has held it in 12 quarters since. The position peaked at $10.4M in Q3 2021. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Balyasny Asset Management held 298,955 shares of Veracyte worth $9.63M as of Q1 2026.
  • Veracyte was a new Balyasny Asset Management position in Q1 2026.
  • Veracyte made up 0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1050 holding.
  • Balyasny Asset Management first reported a position in Veracyte in Q2 2020 and has held it in 12 quarters since.
  • Balyasny Asset Management's Veracyte position peaked at $10.4M in Q3 2021.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.